Sofia S. Haque

74 papers receiving 3.6k citations

Sofia S. Haque's Hit Papers

Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial 2019 · 395 citations
3950+4+8Years since publication200400600

Peers

Sofia S. Haque
Comparison fields: 5 of 81
  • Genetics 667
  • Endocrinology, Diabetes and Metabolism 860
  • Otorhinolaryngology 280
  • Neurology 278
  • Oncology 441
Replace Sofia Asioli with:
Sofia Asioli Italy
Luca Morandi Italy
Jae-Kyung Won South Korea
Sandrine Rorive Belgium
Fumiyuki Yamasaki Japan
Florence de Fraipont France
Hans-Jürgen Holzhausen Germany
Gianluigi Zona Italy
Ho Jun Seol South Korea
Michael Hofmann Germany
Sofia S. Haque relative to Sofia Asioli Italy Sofia Asioli's profile →
Citations per field
00.5×2×3×3.8×
Sofia Asioli · 1×
Citations per year

Countries citing papers authored by Sofia S. Haque

Since Specialization
Citations

This map shows the geographic impact of Sofia S. Haque's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sofia S. Haque with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sofia S. Haque more than expected).

Fields of papers citing papers by Sofia S. Haque

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sofia S. Haque. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sofia S. Haque. The network helps show where Sofia S. Haque may publish in the future.

Co-authors

The 25 scholars most cited alongside Sofia S. Haque, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sofia S. Haque Line = papers co-authored together Sofia S. Haque links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 79 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Selumetinib-Enhanced Radioiodine Uptake in Advanced Thyroid Cancer
Hit paper breakdown →
2013655
2
Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial
Hit paper breakdown →
2019395
3 2018234
4 2018198
5 2019188
6 2019171
7 201699
8 201492
9 199886
10 202278
11
Phase II study of saracatinib (AZD0530) for patients with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC).
201170
12 201267
13 201265
14 201763
15 201261
16 201960
17 201758
18 201655
19 201855
20 200853

About Sofia S. Haque

Sofia S. Haque is a scholar working on Genetics, Otorhinolaryngology, Neurology, Radiology, Nuclear Medicine and Imaging and Endocrinology, Diabetes and Metabolism, having authored 79 papers that have together received 3.6k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (27 papers), Head and Neck Cancer Studies (14 papers), Radiopharmaceutical Chemistry and Applications (6 papers), Thyroid Cancer Diagnosis and Treatment (6 papers), Neurofibromatosis and Schwannoma Cases (5 papers), Ocular Oncology and Treatments (4 papers), Salivary Gland Tumors Diagnosis and Treatment (3 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). The work is most often cited by research in Genetics (667 citations), Endocrinology, Diabetes and Metabolism (860 citations), Otorhinolaryngology (280 citations), Neurology (278 citations) and Oncology (441 citations). Sofia S. Haque has collaborated with scholars based in United States, Germany and Japan. Frequent co-authors include David G. Pfister, Eric Jeffrey Sherman, Alan Loh Ho, Matthew G. Fury, Ronglai Shen, PAT B. ZANZONICO, Steven M. Larson, Ronald A. Ghossein, Nora Katabi and Shrujal S. Baxi. Their work appears in journals such as Neuro-Oncology, Cancer, Pediatric Blood & Cancer, Annals of Oncology and The Lancet Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact